SCHEMBL9150182

SCHEMBL9150182

CCCCC(CCCC)=C(C(N)=O)C(N)CC

nearest known ligand 0.39

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
DDAH1 O94760 2/20 0.39
CA1 P00915 2/20 0.38
CA2 P00918 1/20 0.38
CES1 P23141 2/20 0.38
CES2 O00748 1/20 0.38
DPP7 Q9UHL4 2/20 0.37
DPP4 P27487 1/20 0.37
DPP8 Q6V1X1 1/20 0.37
DPP9 Q86TI2 1/20 0.37
ALDH1A1 P00352 1/20 0.35
TP53 P04637 1/20 0.35
SLC1A2 P43004 2/20 0.34
SLC1A1 P43005 2/20 0.34
SLC1A3 P43003 1/20 0.34
GRIK1 P39086 1/20 0.33
GRIK2 Q13002 1/20 0.33
NOS1 P29475 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27300733 0.88 DDAH1 (0.35) DDAH1CA1CA2CES1CES2
SCHEMBL1072346 0.79 GRIK1 (0.39) DDAH1CA1CA2DPP7DPP4
SCHEMBL27301690 0.74 CES2 (0.35) DDAH1CA1CA2CES1CES2
SCHEMBL28004467 0.73 FAAH (0.36) DDAH1CA1CA2CES1CES2
SCHEMBL36268 0.73 SLC1A3 (0.35) CA1CA2DPP7DPP4DPP8
SCHEMBL27505015 0.72 DDAH1 (0.38) DDAH1CA1CA2CES1CES2
Hydrochloric Acid SCHEMBL27679824 0.71 SLC1A3 (0.34) CA1CA2DPP7DPP4DPP8
Chloromethane SCHEMBL533996 0.69 SLC1A3 (0.33) SLC1A2SLC1A1SLC1A3GRIK1
SCHEMBL8743057 0.69 CES1 (0.46) CA1CES1CES2ALDH1A1TP53
SCHEMBL2469796 0.69 CES1 (0.46) CA1CES1CES2ALDH1A1TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11717471-B2 Hydrogel microcapsules ISP INVESTMENTS LLC (US) 2023-08-08 US disclosed
US-20130302392-A1 HYDROGEL MICROCAPSULES HERCULES LLC 2013-11-14 US disclosed
EP-2646002-A2 HYDROGEL MICROCAPSULES Isp Investments Inc. (US) 2013-10-09 EP disclosed
WO-2012075293-A2 HYDROGEL MICROCAPSULES ISP INVESTMENTS INC. (US) 2012-06-07 WO disclosed
US-5478631-A Ink receptive layer containing pigment and binder of amphoteric latex KANZAKI PAPER MFG. CO., LTD. (JP) 1995-12-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11717471-B2 Hydrogel microcapsules MITF, DSG1, SHH DDAH1 299/4885CA1 3646/4885CA2 3084/4885
US-20130302392-A1 HYDROGEL MICROCAPSULES MITF, DSG1, SHH DDAH1 299/4885CA1 3646/4885CA2 3084/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.